100% Quality Guarantee
PhD-Level Technical Support
Epigenetics and Nuclear Signaling Antibodies 3 Anti-BRD3 Antibody CAB2277
Key Features

BRD3 Rabbit Polyclonal Antibody (CAB2277)

SKU CAB2277
Product Type Antibody
Antibody Type Polyclonal Antibody
Reactivity Human, Rat
Host Species Rabbit
Synonyms ORFX, FSHRG2, RING3L, BRD3
Research Use Epigenetics and Nuclear Signaling
€96 - €370

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheetsystem_update_altMSDS

BRD3 Antibody (CAB2277)

The BRD3 Antibody (CAB2277) is a high-quality antibody developed for reliable detection and analysis of target proteins. This antibody, produced in rabbits, is specifically designed for detecting and analyzing BRD3 protein in human samples. Validated for use in Western blot applications, this antibody offers high reactivity and specificity for studying BRD3 in various cell types.BRD3 is a member of the bromodomain and extraterminal domain (BET) family of proteins, known for their role in gene regulation and transcriptional activation. BRD3 specifically plays a crucial role in cell proliferation, differentiation, and oncogenesis, making it a promising target for cancer research and therapeutic development.

This antibody is validated for use in WB, IHC-P, ELISA applications and has demonstrated reactivity against Human, Rat samples.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose